EnWave Posts 36% Revenue Growth on Machine Sales and Royalty Boost
Event summary
- Q1 2026 revenue rose 36% YoY to $1.6M CAD, driven by large-scale machine sales and royalty growth.
- Base royalties increased 18% YoY to $500K CAD, with total royalties up 12% to $627K CAD.
- Gross margin improved to 37% from 29% YoY, attributed to higher royalties and machine production mix.
- Adjusted EBITDA loss narrowed by $50K YoY to $585K CAD despite a 16% increase in operating expenses.
- Signed three commercial license agreements (CLAs) with partners in Australia, New Zealand, and the U.S.
The big picture
EnWave's Q1 2026 results reflect its strategy of leveraging royalty-bearing commercial licenses to drive growth in food, cannabis, and pharmaceutical drying solutions. The 36% revenue increase underscores demand for its REV™ technology, particularly in large-scale applications. However, the company must manage rising operating expenses while scaling its machine sales and royalty partnerships to achieve profitability.
What we're watching
- Royalty Expansion
- Whether EnWave can sustain royalty growth through increased partner production and exclusivity payments.
- Machine Sales
- The pace at which large-scale machine sales and fabrication contracts convert into recurring revenue.
- Cost Control
- How EnWave balances rising SG&A costs with margin expansion, particularly in sales and R&D.
Related topics